JG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of AbbVie Inc. (ABBV) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on Mar 17, 2023.
The trade happened on Feb 21, 2023, 24 days before it was made public.
ABBV has moved +73.0% since the trade date, from $152.00 to $262.90 (Oct 2, 2026 close).
- Traded
- Feb 21, 2023
- Disclosed
- Mar 17, 2023
- Filing delay
- 24 days
- Price since
- +73.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (57)
- BuyMSFT$1M-$5MMar 17, 2023
- SellMSFT$1M-$5MMar 17, 2023
- BuyMSFT$1M-$5MMar 17, 2023
- SellMSFT$1M-$5MMar 17, 2023
- BuyMSFT$500K-$1MMar 17, 2023
- SellMSFT$500K-$1MMar 17, 2023
- SellMSFT$500K-$1MMar 17, 2023
- SellMSFT$250K-$500KMar 17, 2023
- BuyAAGIY$1K-$15KMar 17, 2023
- SellABBV$1K-$15KMar 17, 2023
- BuyADBE$1K-$15KMar 17, 2023
- BuyADBE$1K-$15KMar 17, 2023
- SellADP$1K-$15KMar 17, 2023
- SellAMD$1K-$15KMar 17, 2023
- SellAMD$1K-$15KMar 17, 2023
- BuyAMD$1K-$15KMar 17, 2023
- SellAMGN$1K-$15KMar 17, 2023
- BuyAPPF$1K-$15KMar 17, 2023
- SellAZO$1K-$15KMar 17, 2023
- SellAZO$1K-$15KMar 17, 2023
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.